A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V97.1.56PMID 11133742
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of acute myeloid leukemia.

  1999cited by this paper
• Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group.

  1999cited by this paper
• Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821.

  1999cited by this paper
• Treatment of acute myeloid leukemia.

  1999cited by this paper
• Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial

  1998cited by this paper
• Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.

  1998cited by this paper
• Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• Transplantation in first remission of acute myeloid leukemia.

  1998cited by this paper
• Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

  1998cited by this paper
• A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

  1996cited by this paper
• Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood

  1996cited by this paper
• Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.

  1996cited by this paper
• Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group.

  1996cited by this paper
• Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

  1995cited by this paper
• Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group.

  1994cited by this paper
• Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.

  1994cited by this paper
• Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group.

  1993cited by this paper
• Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group.

  1993cited by this paper
• Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission.

  1993cited by this paper
• Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.

  1993cited by this paper
• Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.

  1990cited by this paper
• The role of timing of high‐dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia

  1990cited by this paper
• Improvement in outcome for children with acute nonlymphocytic leukemia. A report from the childrens cancer study group

  1989cited by this paper
• The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.

  1987cited by this paper
• Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.

  1986cited by this paper
• Asymptotically Efficient Rank Invariant Test Procedures

  1972cited by this paper

• Clinical Outcomes of Acute Leukemia in Children Less Than 2 Years: Experience from a Tertiary Center in Thailand

  2025influential citation
• Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry

  2025cites this paper
• Results of allogeneic hematopoietic stem cell transplantation from a genoidentical sibling after high-dose treosulfan-based conditioning in children with intermediate-risk acute myeloid leukemia in first clinical and hematological remission

  2025cites this paper
• Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of clinical choice for AML

  2024cites this paper
• Comparison of vital status, cause of death, and follow-up after HCT in linked CIBMTR and California Cancer Registry data, 1991-2018.

  2023cites this paper
• Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review

  2023cites this paper
• Comparison of pulmonary toxicity after total body irradiation- and busulfan-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation for pediatric patients.

  2022cites this paper
• Pediatric Acute Myeloid Leukemia—Past, Present, and Future

  2022cites this paper
• Chronic Conditions, Late Mortality and Health Status After Childhood AML: A Childhood Cancer Survivor Study Report.

  2022cites this paper
• The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia

  2021cites this paper
• Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

  2021cites this paper
• Autologous Hematopoietic Stem Cell Transplant: A Potential Option for Relapsed Pediatric Acute Myeloid Leukemia With Lack of Matched Sibling Donor and Resource Challenge

  2021cites this paper
• Population Pharmacokinetics and Safety of Dasatinib in Chinese Children with Core-Binding Factor Acute Myeloid Leukemia

  2021cites this paper
• ALLOGENEIC BONE MARROW TRANSPLANTATION IN MULTIPLE MYELOMA-A REVIEW OF LITERATURE

  2020cites this paper
• Acute Monocytic Leukemia

  2020cites this paper
• Allogeneic Haemopoietic Stem Cell Transplantation

  2020cites this paper
• V+ model-a Medical Perspective for Device Development

  2020cites this paper
• Hematopoietic stem cell transplantation for pediatric acute promyelocytic leukemia in Japan

  2020cites this paper
• Cryo-shocked cancer cells for targeted drug delivery and vaccination

  2020cites this paper
• Treatment of Childhood Acute Myeloid Leukemia in Uruguay: Results of 2 Consecutive Protocols Over 20 Years

  2020influential citation
• Treatments for children and adolescents with AML

  2019cites this paper
• 2004 Cancer Care Annual Report

  2019cites this paper
• One-Hundred Day after Bone Marrow Transplantation: Oral and Dental Status in Children

  2019cites this paper
• Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial

  2019cites this paper
• Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases

  2019influential citation
• Outcome of Acute Myeloid Leukemia in Children Adolescents and Young Adults Treated with an Uniform Protocol in Casablanca, Morocco

  2018cites this paper
• Acute Myeloid Leukemia in Pediatric Patients: A Review About Current Diagnostic and Treatment Approaches

  2018cites this paper
• A Chemotherapy-only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit ATG followed by Allogeneic T-cell Depleted Hematopoietic Stem Cell Transplants for the Treatment of Myeloid Malignancies

  2018cites this paper
• Allogeneic Stem Cell Transplantation

  2018cites this paper
• Improvement of treatment outcome over 2 decades in children with acute myeloid leukemia

  2018cites this paper
• Trasplante de células madre hematopoyéticas en pacientes pediátricos con diagnóstico de neoplasias mieloides, experiencia en 15 años

  2018cites this paper
• Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012

  2018cites this paper
• Acute Myeloid Leukemia in Children

  2018cites this paper
• 10 Pediatric Acute Myeloid Leukemia

  2018cites this paper
• Indications for Hematopoietic Stem Cell Transplantation in Children

  2018cites this paper
• Treatment of Childhood Acute Myeloid Leukemia in Bulgaria

  2018cites this paper
• Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study

  2018cites this paper
• Comparison of conditioning regimens for autologous stem cell transplantation in children with acute myeloid leukemia: A nationwide retrospective study in Japan

  2018cites this paper
• A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.

  2017cites this paper
• Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group

  2017cites this paper
• Hematopoietic stem cell transplantation in pediatric patients with acute myeloid leukemia without favorable cytogenetics

  2017cites this paper
• differentiation therapy of myeloid leukemia reversing maturation arrest

  2017cites this paper
• The evolution of allogeneic stem cell transplant for children and adolescents with acute myeloid leukemia.

  2017cites this paper
• A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.

  2016cites this paper
• Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation in First Complete Remission Can Abrogate the Poor Outcomes of Children with Acute Myeloid Leukemia Resistant to the First Course of Induction Chemotherapy.

  2016cites this paper
• Hematopoietic Cell Transplantation for Childhood Acute Myeloid Leukemia

  2016cites this paper
• Introduction: Childhood Leukemia

  2016cites this paper
• Role of nucleolar protein NOM1 in pancreatic islet β cell apoptosis in diabetes.

  2016cites this paper
• Outcomes of Hematopoietic Stem Cell Transplantation by Donor Types in Children with Acute Myeloid Leukemia

  2016cites this paper
• Acute myeloid leukemia in children: Current status and future directions

  2016cites this paper
• Clinical characteristics and outcome of childhood de novo acute myeloid leukemia in Saudi Arabia: A multicenter SAPHOS leukemia group study.

  2016cites this paper
• Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations

  2016cites this paper
• Different aspects of stem cell procedures in children with poor responding AML: when is HSCT the best answer?

  2015cites this paper
• Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients

  2015cites this paper
• Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial

  2015cites this paper
• Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.

  2015cites this paper
• Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia

  2015cites this paper
• Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants.

  2015cites this paper
• Survival of Mexican Children with Acute Myeloid Leukaemia Who Received Early Intensification Chemotherapy and an Autologous Transplant

  2015cites this paper
• Diagnosis and Treatment of Pediatric Acute Myeloid Leukemia

  2015cites this paper
• Évolution du pronostic des leucémies aiguës myéloïdes de l’enfant de moins de 1 an traitées dans les protocoles successifs : LAME 89/91, LAME 89/93 et ELAM02

  2015cites this paper
• Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia

  2015cites this paper
• Biology and Therapeutic Implications of Genomic Variants

  2015cites this paper
• Immunotherapy of Leukemic Stem Cells using Natural Killer Cell Lines

  2015cites this paper
• Hematopoietic Stem Cell Transplantation in Children with Acute Myeloblastic Leukemia

  2014cites this paper
• Arşiv Kaynak Tarama Dergisi Archives Medical Review Journal

  2014cites this paper
• A critical review of which children with acute myeloid leukaemia need stem cell procedures

  2014cites this paper
• Overview of Therapy and Strategies for Optimizing Outcomes in De Novo Pediatric Acute Myeloid Leukemia

  2014cites this paper
• Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: A report from the children's oncology group

  2014cites this paper
• Cord Blood Transplantation for Pediatric Hematologic Malignancies: Indications, Mechanisms, and Outcomes

  2014cites this paper
• Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.

  2014cites this paper
• Development of treatment and clinical results in childhood AML in Austria (1993–2013)

  2014cites this paper
• Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #110

  2014cites this paper
• Autologous Transplantation in 1st Cr Aml Patients with Purged or Unpurged Bone Marrow: Good Clinical Results in Favorable CytogeneticGroup and in those Infused with a Low Number of Marrow Cells

  2014cites this paper
• Qualification biologique des greffons de tissu ovarien autoconservé : Contribution à la recherche de maladie résiduelle en cas de pathologie néoplasique

  2014cites this paper
• Transactivating Target Gene Expression by Recombinant SALL4B: A Pluripotent Stem Cell Marker

  2014cites this paper
• Optimal dose and schedule of consolidation in AML: is there a standard?

  2014cites this paper
• Development of a Curative Treatment within the AML-BFM Studies

  2013cites this paper
• Diagnosis and management of childhood myelodysplastic syndrome and juvenile myelomonocytic leukemia

  2013cites this paper
• Study Group myeloid leukemia from the Australian and New Zealand Children's Cancer Results of consecutive trials for children newly diagnosed with acute

  2013cites this paper
• Diagnosis and Treatment of Childhood Acute Myeloid Leukemia

  2013cites this paper
• Autologous bone marrow transplantation in acute myeloid leukemia

  2013cites this paper
• the Children's Oncology Group Ethnicity and survival in childhood acute myeloid leukemia: a report from

  2013cites this paper
• Acute myeloid leukemia commentary

  2013cites this paper
• donors in pediatric leukemia Transplantation of highly purified CD34+ progenitor cells from unrelated

  2013cites this paper
• Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients

  2013influential citation
• of hematologic remission in children with acute myeloid leukemia Emergence of antitumor cytolytic T cells is associated with maintenance

  2013cites this paper
• Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research.

  2013cites this paper
• adolescents: recommendations from an international expert panel Diagnosis and management of acute myeloid leukemia in children and

  2013cites this paper
• resistance leukemia: prognostic significance and relation to cellular drug FLT3 internal tandem duplication in 234 children with acute myeloid

  2013cites this paper
• Diagnosis and Treatment of Adult Acute Myeloid Leukemia Other than Acute Promyelocytic Leukemia

  2013cites this paper
• advanced CD33+ acute myeloid leukemia Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with

  2013cites this paper
• Children's Oncology Group untreated pediatric acute myeloid leukemia (AML): a report from the Outcomes in CCG-2961, a Children's Oncology Group phase 3 trial for

  2013cites this paper
• Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials

  2013cites this paper
• Acute myeloid leukaemia - therapy - past, present and future

  2013cites this paper
• Comparing sources of stem cells for transfusion inacute myeloid leukemia

  2013cites this paper
• Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia

  2013cites this paper
• Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia.

  2013cites this paper
• Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006–2010): based on registry data from the Japanese Society of Pediatric Hematology

  2013cites this paper
• Hematopoietic cell transplantation in high-risk childhood acute myelogenous leukemia.

  2013cites this paper